HALO - Halozyme Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$110.00
DETAILS
HIGH:
$130.00
LOW:
$90.00
MEDIAN:
$107.50
CONSENSUS:
$110.00
DOWNSIDE:
9.72%
Institutional Holders (13F)
| GURU | SHARES | VALUE | WEIGHT % | SHARES CHG | ACTION |
|---|---|---|---|---|---|
| Greenblatt | 739,273 | $57.9M | 0.1% | -7,568 | DECREASED |
| Dalio | 463,146 | $36.3M | 0.1% | -48,283 | DECREASED |
| Cooperman | 28,200 | $2.2M | 0.0% | +7,300 | INCREASED |
Insider Trading
| DATE | INSIDER | TITLE | TYPE | SHARES | PRICE | VALUE |
|---|---|---|---|---|---|---|
| 2026-10-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 3,090 | $108.91 | $337K |
| 2026-10-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 4,810 | $108.18 | $520K |
| 2026-10-07 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 8,600 | $111.03 | $955K |
| 2026-10-07 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 10,300 | $111.84 | $1.2M |
| 2026-10-06 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 2,300 | $107.90 | $248K |
| 2026-10-06 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 9,920 | $109.89 | $1.1M |
| 2026-10-07 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 900 | $112.78 | $102K |
| 2026-10-06 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 6,000 | $109.33 | $656K |
| 2026-10-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 11,900 | $110.00 | $1.3M |
| 2026-10-07 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 200 | $113.69 | $23K |
| 2026-10-06 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 1,780 | $110.81 | $197K |
| 2026-10-06 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-10-07 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-05-05 | Connaughton Bernadette | director | A-Award | 3,796 | -- | -- |
| 2026-10-08 | Torley Helen | director, officer: PRESIDENT AND CEO | SELL | 200 | $110.51 | $22K |
| 2026-10-08 | Torley Helen | director, officer: PRESIDENT AND CEO | M-Exempt | 20,000 | $18.41 | $368K |
| 2026-10-01 | Daly James M | director | A-Award | 1,775 | $106.94 | $190K |
| 2026-10-01 | Daly James M | director | A-Award | 1,169 | -- | -- |
| 2026-09-28 | Daly James M | director: | ? | -- | -- | -- |
| 2026-10-01 | Posard Matthew L. | director | SELL | 100 | $110.04 | $11K |
| 2026-10-01 | Posard Matthew L. | director | SELL | 730 | $107.17 | $78K |
| 2026-10-01 | Posard Matthew L. | director | SELL | 3,300 | $108.45 | $358K |
| 2026-10-01 | Posard Matthew L. | director | SELL | 1,100 | $109.57 | $121K |
| 2026-09-16 | Posard Matthew L. | director | SELL | 4,000 | $108.99 | $436K |
| 2026-09-16 | Posard Matthew L. | director | SELL | 3,100 | $106.13 | $329K |
Congressional Trading
| DATE | MEMBER | CHAMBER | TYPE | AMOUNT |
|---|---|---|---|---|
| 2026-10-12 | Gilbert Cisneros | HOUSE | Sale (Partial) | $1,001 - $15,000 |